Suchergebnisse - "Roy, Nilmadhab"

PubPharm (16)

1

Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes : an exploration of new perspectives for anticancer chemotherapeutics

enthalten in: RSC advances | 2023

von Roy, N. | Das, R. | Paira, R. | +1

2

G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2'-Bipyrimidine-Based Heterobimetallic Luminescent Complexes : An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells

enthalten in: ACS omega | 2023

von Roy, N. | Shanavas, S. | Kar, B. | +7

3

Luminescent 11-{Naphthalen-1-yl}dipyrido[3,2-a:2',3'-c]phenazine-Based Ru(II)/Ir(III)/Re(I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy

enthalten in: ACS applied bio materials | 2023

von Das, U. | Shanavas, S. | Nagendra, A. | +7

4

Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model

enthalten in: RSC advances | 2022

von P K, A. | Kar, B. | Roy, N. | +1

5

Ru(η6-p-cymene)(N^O 8-hydroxyquinoline)(PTA)] complexes as rising stars in medicinal chemistry : synthesis, properties, biomolecular interactions, in vitro anti-tumor activity toward human brain carcinomas, and in vivo biodistribution and toxicity in a zebrafish model

enthalten in: Dalton transactions (Cambridge, England : 2003) | 2022

von P K, A. | Roy, N. | Das, U. | +3

6

Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468

enthalten in: RSC advances | 2022

von Mondal, A. | Shanavas, S. | Sen, U. | +4

7

Iridium(III)-Cp*-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents

enthalten in: Dalton transactions (Cambridge, England : 2003) | 2022

von Kar, B. | Shanavas, S. | Nagendra, A. | +12

8

2,2'-Bipyrimidine-based luminescent Ru(ii)/Ir(iii)-arene monometallic and homo- and hetero-bimetallic complexes for therapy against MDA-MB-468 and caco-2 cells

enthalten in: Dalton transactions (Cambridge, England : 2003) | 2021

von Roy, N. | Sen, U. | Moharana, P. | +6

9

GSH-resistant and highly cytoselective ruthenium(II)-p-cymene-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agents

enthalten in: Dalton transactions (Cambridge, England : 2003) | 2021

von Kar, B. | Das, U. | De, S. | +6

10

Mitochondria specific highly cytoselective iridium(iii)-Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents

enthalten in: Dalton transactions (Cambridge, England : 2003) | 2021

von Roy, N. | Sen, U. | Ray Chaudhuri, S. | +6